Navigation Links
Evaluating The Risks and Benefits of Hormone Therapy

In a study done on the risks and benefits of short-term use of hormone therapy in menopausal women it was found that women can // increase their quality of life, but they may also shorten their life expectancy if they use hormone therapy.

Deciding whether or not to use hormone therapy can be a difficult decision. Hormone therapy can be an effective treatment for menopausal symptoms, but are the risks worth the benefits? Question researchers . In a recent study conducted researchers investigated the precise risks and benefits of short-term hormone therapy .

For the study, researchers developed a Web-based computer model to simulate the effects of two years of hormone therapy use. They looked at life expectancy and the improved quality of life among 50-year-old menopausal women. The computer model was based on findings from the Women’s Health Initiative, a 15-year-long research project.

It was observed that for women without any menopausal symptoms, short term hormone therapy resulted in a net loss in life expectancy and quality of life expectancy of one to three months. Women with symptoms gained seven to eight months of improved quality of life, but a shortened overall survival.

Researchers conclude saying that short-term hormone therapy can be both harmful and beneficial. The decision to use it depends on a woman’s treatment goals. If the goal is to maximize the quality of life, then hormone therapy is beneficial. However, if the goal is to live longer, they do not recommend hormone therapy.
'"/>




Page: 1

Related medicine news :

1. Evaluating The Risk Factors Of Osteoporosis
2. Evaluating The Benefits Of A Low – carb Diet
3. Simvastatin Plus Niacin May Lower Heart Risks
4. Risks for Silent Strokes
5. Ginseng Associated with Pregnancy Risks
6. Benefits and Risks of Asthma Treatment Questioned
7. Lack of Smell And Its Potential Risks
8. A Slight Increase In BP Can Mean big Risks
9. The Risks Of Smoking
10. Risks Of An Enlarged Heart
11. Identifying The Risks Of Developing Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... Tucson, AZ (PRWEB) , ... February 10, 2016 , ... ... prompted the Aging Life Care Association™ (ALCA) to conduct a survey that takes a ... aging experts released today illustrates the prevalence and causes of TBI among the aging ...
(Date:2/10/2016)... ... 10, 2016 , ... United Benefit Advisors (UBA), the nation’s ... to its growing list of Partner Firms. S.S. Nesbitt is headquartered in ... Huntsville and in between. , Harnessing the experience and insights of the agency’s ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... AxoGen, Inc. ... will report results for the fourth quarter and full year ended December 31, 2015 ... a conference call and webcast for the investment community following the release at 4:30 ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The Association for ... speaker Jan Fox will serve as keynote speaker at the organization’s 2016 Spring ... tools to more effectively communicate with their own organizational staff and leadership. ...
(Date:2/10/2016)... AZ (PRWEB) , ... February 10, 2016 , ... For ... in new book , Pioneering book "Better with Age: The Ultimate Guide to Brain ... neuroplasticity can improve memory. The book’s publication date is March 16, 2016. ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... NEW YORK , Feb. 10, 2016 ... clinical-stage biopharmaceutical company, announced today that it has filed ... Myeloid Leukemia and other cancers. --> ... of treating cancer by administration of Ceplene (histamine dihydrochloride) ... also provides methods of predicting the efficacy of Ceplene ...
(Date:2/10/2016)... , Feb. 10, 2016  Oxis International Inc. ... drug, OXS-1550, was described as a "clinical trial triumph" ... drug went into complete cancer remission. ... of Minnesota Masonic Cancer Center. --> ... of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology: